摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氨基-4-羟基-5-硝基苯-1-磺酸水合物 | 175278-60-1

中文名称
3-氨基-4-羟基-5-硝基苯-1-磺酸水合物
中文别名
3-氨基-4-羟基-5-硝基苯磺酸一水化物;3-氨基-4-羟基-5-硝基苯磺酸一水
英文名称
3-Amino-4-hydroxy-5-nitrobenzene-1-sulfonic acid hydrate
英文别名
3-amino-4-hydroxy-5-nitrobenzenesulfonic acid;hydrate
3-氨基-4-羟基-5-硝基苯-1-磺酸水合物化学式
CAS
175278-60-1
化学式
C6H8N2O7S
mdl
——
分子量
252.2
InChiKey
HJASIPICABEOAV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    299-301°C (dec.)

计算性质

  • 辛醇/水分配系数(LogP):
    -0.7
  • 重原子数:
    16
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    156
  • 氢给体数:
    4
  • 氢受体数:
    8

安全信息

  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2922299090

文献信息

  • Deodorizer and method for using the same
    申请人:Fujii Hiroyuki
    公开号:US20080075686A1
    公开(公告)日:2008-03-27
    A deodorizer is disclosed which is superior both in odor elimination effect eliminating an already existing odor and in odor prevention effect preventing odor occurrence, without leaving a colored trace on an application site. The deodorizer of the present invention comprises a salt of copper (II) ion and/or zinc ion; at least one acid component selected from the group consisting of alkylsulfonic acids having 1 to 6 carbon atoms, arylsulfonic acids having 5 to 14 carbon atoms, amidosulfuric acids, and derivatives thereof; and water being a solvent. The acid component may be substituted by at least one selected from the group consisting of amine groups, imine groups, and hydroxyl group. The deodorizer comprises the salt in an amount of more than 0.001 mM and less than 10 mM.
  • CALCIUM SEQUESTRATION COMPOSITIONS AND METHODS OF TREATING SKIN PIGMENTATION DISORDERS AND CONDITIONS
    申请人:Neocuitis S.A.
    公开号:US20160030321A1
    公开(公告)日:2016-02-04
    The present invention provides compositions containing one or more calcium sequestration agents and methods for topical application of such compositions to the skin to treat skin pigmentation disorders, such as melasma, post-inflammatory hyperpigmentation, pigmentation changes due to skin aging, or any other skin conditions related with normal such as skin of color or abnormal pigmentation such as hypo- or hyper-pigmentation in humans.
  • US9326930B2
    申请人:——
    公开号:US9326930B2
    公开(公告)日:2016-05-03
查看更多